Seres Therapeutics MCRB Growth Metrics (2015-2026)

NASDAQ MCRB
$5.13 -0.15 (-2.84%)
As of: Sep 10, 2026 · 3:52 PM EDT
Reported Financials

Seres Therapeutics Quarterly Growth Metrics

Periods 43 quarters
Latest Jun 2026

Seres Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 43 quarters of results from Dec 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
0.22M-0.06M-0.31M-0.43M-0.18M0.05M-0.98M0.52M-1.27M0.02M
EBITDA Margin Growth (3y)
0.03M-0.05M-0.34M-0.51M-0.15M0.02M-1.33M0.04M-1.23M0.01M-0.47M-0.42M0.77M-0.29M
EBITDA Margin Growth (5y)
0.02M0.02M-0.29M-0.43M-0.17M0.08M-1.28M0.06M-1.41M0.02M-0.43M-0.43M-0.52M-0.20M
EBITDA Margin (QoQ)
0.10M-0.07M-0.30M-0.15M0.35M0.15M-1.33M1.36M-1.44M1.44M0.20M-0.14M0.29M
EBIT Margin Growth (1y)
0.22M-0.06M-0.31M-0.43M-0.18M0.05M-0.98M0.52M-1.27M0.02M
EBIT Margin Growth (3y)
0.03M-0.05M-0.34M-0.51M-0.15M0.02M-1.33M0.04M-1.23M0.01M-0.47M-0.42M0.77M-0.29M
EBIT Margin Growth (5y)
0.02M0.02M-0.29M-0.43M-0.17M0.08M-1.28M0.06M-1.41M0.02M-0.43M-0.43M-0.52M-0.20M
EBIT Margin (QoQ)
0.10M-0.07M-0.30M-0.15M0.35M0.15M-1.33M1.36M-1.44M1.44M0.20M-0.14M0.29M
EBT Margin Growth (1y)
0.22M-0.06M-0.32M-0.44M-0.18M0.05M-0.99M0.53M-1.18M0.03M
EBT Margin Growth (3y)
0.03M-0.05M-0.34M-0.52M-0.15M0.01M-1.34M0.04M-1.14M0.01M-0.45M-0.41M0.79M-0.29M
EBT Margin Growth (5y)
0.02M0.02M-0.29M-0.44M-0.17M0.07M-1.30M0.06M-1.33M0.02M-0.41M-0.42M-0.51M-0.20M
EBT Margin (QoQ)
0.10M-0.07M-0.31M-0.15M0.36M0.15M-1.35M1.37M-1.36M1.36M0.19M-0.14M0.29M
FCF Margin Growth (1y)
0.19M-0.06M-0.41M-0.35M-0.19M-0.50M-1.08M0.43M-1.79M0.58M
FCF Margin Growth (3y)
0.04M-0.09M-0.42M-0.42M-0.15M-0.55M-1.52M0.05M-1.79M0.01M0.24M0.24M1.09M-0.31M
FCF Margin Growth (5y)
0.02M0.01M-0.37M-0.34M-0.17M-0.51M-1.48M0.06M-1.94M-0.01M0.25M-0.33M-0.40M-0.22M
FCF Margin (QoQ)
0.09M-0.08M-0.39M0.04M0.25M-0.40M-0.97M1.55M-1.97M1.97M-0.40M-0.12M0.15M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
323.77%-184.05%-20.44%35.85%-137.22%98.63%40.74%136.83%-53.83%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-9.62%36.51%-3.16%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
239.80%-172.85%8.73%30.99%18.88%97.31%-3,834.41%142.90%
Net Margin Growth (1y)
0.22M-0.06M-0.32M-0.44M-0.18M0.05M-0.99M0.53M-1.40M0.03M
Net Margin Growth (3y)
0.03M-0.05M-0.34M-0.52M-0.15M0.01M-1.34M0.04M-1.36M0.01M-0.45M-0.41M0.79M-0.29M
Net Margin Growth (5y)
0.02M0.02M-0.29M-0.44M-0.17M0.07M-1.30M0.06M-1.55M0.02M-0.41M-0.42M-0.51M-0.20M
Net Margin (QoQ)
0.10M-0.07M-0.31M-0.15M0.36M0.15M-1.35M1.37M-1.58M1.58M0.19M-0.14M0.29M
Operating Margin Growth (1y)
0.22M-0.06M-0.31M-0.43M-0.18M0.05M-0.98M0.52M-1.27M0.02M
Operating Margin Growth (3y)
0.03M-0.05M-0.34M-0.51M-0.15M0.02M-1.33M0.04M-1.23M0.01M-0.47M-0.42M0.77M-0.29M
Operating Margin Growth (5y)
0.02M0.02M-0.29M-0.43M-0.17M0.08M-1.28M0.06M-1.41M0.02M-0.43M-0.43M-0.52M-0.20M
Operating Margin (QoQ)
0.10M-0.07M-0.30M-0.15M0.35M0.15M-1.33M1.36M-1.44M1.44M0.20M-0.14M0.29M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M859.00693.000.00M-0.01M-0.00M-0.00M914.000.01M0.00M0.00M-0.00M0.00M0.00M0.00M0.01M-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.01M0.01M0.00M-0.00M-14.00-907.000.00M0.00M-558.00863.00-409.00778.000.00M0.00M0.01M829.00-978.00-301.00-0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M805.00-0.00M-0.00M-0.00M0.00M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M-0.00M-0.00M-0.00M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M-730.00-824.00-903.00-0.00M0.00M-864.000.00M606.00-0.00M763.00-0.00M0.00M708.00946.00629.00-0.01M532.00-187.00-823.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M708.00423.00850.00-0.01M-0.01M-0.00M0.00M0.01M0.00M0.01M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M0.00M0.00M-432.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.01M0.01M0.00M-0.00M0.00M730.000.01M0.00M-974.000.00M-818.00-0.01M-0.01M-0.01M-0.00M0.00M-382.00-147.00-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M938.0011.00-0.01M-0.00M-0.00M0.01M0.01M0.01M0.01M0.00M0.00M-0.00M-800.000.00M-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M-816.00-0.00M-0.00M-0.01M0.00M-575.000.00M956.00-0.00M0.00M-0.00M-493.00-0.00M820.00507.00416.00800.00-339.00-0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.22M-0.06M-0.31M-0.43M-0.18M0.05M-0.98M0.52M-1.27M0.02M0.08M0.01M1.45M-0.65M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.03M-0.05M-0.34M-0.51M-0.15M0.02M-1.33M0.04M-1.23M0.01M-1.21M0.10M0.00M-0.47M-0.42M0.77M-0.29M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
0.02M0.02M-0.29M-0.43M-0.17M0.08M-1.28M0.06M-1.41M0.02M-1.24M0.02M0.03M-0.43M-0.43M-0.52M-0.20M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.10M-0.07M-0.30M-0.15M0.35M0.15M-1.33M1.36M-1.44M1.44M-1.28M1.29M-0.00M0.20M-0.14M0.29M